BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 27412356)

  • 1. Rapid species identification and epidemiological analysis of carbapenem-resistant Acinetobacter spp. by a PCR-based open reading frame typing method.
    Yamada Y; Endo K; Sawase K; Anetai M; Narita K; Hatakeyama Y; Ishifuji K; Kurota M; Suwabe A
    J Med Microbiol; 2016 Sep; 65(9):923-927. PubMed ID: 27412356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of Three Different Methods in Investigating the Molecular Epidemiology of Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates].
    Uluçam Atay G; Bayramoğlu G; Tosun İ; Ünsal Ü
    Mikrobiyol Bul; 2024 Apr; 58(2):97-112. PubMed ID: 38676579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbapenem resistance in a human clinical isolate identified to be closely related to Acinetobacter indicus.
    Bonnin RA; Poirel L; van der Reijden TJ; Dijkshoorn L; Lescat M; Nordmann P
    Int J Antimicrob Agents; 2014 Oct; 44(4):345-50. PubMed ID: 25245212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Investigation of Carbapenem-Resistant Acinetobacter spp. from Hospitals in North Rhine-Westphalia, Germany.
    Rieber H; Frontzek A; Pfeifer Y
    Microb Drug Resist; 2017 Jan; 23(1):25-31. PubMed ID: 27093111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea.
    Park YK; Jung SI; Park KH; Kim SH; Ko KS
    Int J Antimicrob Agents; 2012 Jan; 39(1):81-5. PubMed ID: 21996405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
    Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
    Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct Genetic Diversity of Carbapenem-Resistant Acinetobacter baumannii from Colombian Hospitals.
    Correa A; Del Campo R; Escandón-Vargas K; Perenguez M; Rodríguez-Baños M; Hernández-Gómez C; Pallares C; Perez F; Arias CA; Cantón R; Villegas MV
    Microb Drug Resist; 2018; 24(1):48-54. PubMed ID: 28570118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of carbapenem-non-susceptible Acinetobacter spp. in Japan: predominance of multidrug-resistant Acinetobacter baumannii clonal complex 92 and IMP-type metallo-β-lactamase-producing non-baumannii Acinetobacter species.
    Kouyama Y; Harada S; Ishii Y; Saga T; Yoshizumi A; Tateda K; Yamaguchi K
    J Infect Chemother; 2012 Aug; 18(4):522-8. PubMed ID: 22327516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OXA-Carbapenemases Present in Clinical Acinetobacter baumannii-calcoaceticus Complex Isolates from Patients in Kurdistan Region, Iraq.
    Ganjo AR; Maghdid DM; Mansoor IY; Kok DJ; Severin JA; Verbrugh HA; Kreft D; Fatah MH; Alnakshabandi AA; Dlnya A; Hammerum AM; Ng K; Goessens W
    Microb Drug Resist; 2016 Dec; 22(8):627-637. PubMed ID: 27003287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of NDM-producing non-baumannii Acinetobacter spp. isolated from China.
    Zhang R; Hu YY; Yang XF; Gu DX; Zhou HW; Hu QF; Zhao K; Yu SF; Chen GX
    Eur J Clin Microbiol Infect Dis; 2014 May; 33(5):853-60. PubMed ID: 24306098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wide spread of OXA-23-producing carbapenem-resistant Acinetobacter baumannii belonging to clonal complex II in different hospitals in Lebanon.
    Al Atrouni A; Hamze M; Jisr T; Lemarié C; Eveillard M; Joly-Guillou ML; Kempf M
    Int J Infect Dis; 2016 Nov; 52():29-36. PubMed ID: 27663910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed identification of Acinetobacter baumannii during an outbreak owing to disrupted bla
    Ahmadi A; Salimizand H
    Int J Antimicrob Agents; 2017 Jul; 50(1):119-122. PubMed ID: 28533186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of carbapenem resistance determinants among epidemic and non-epidemic types of Acinetobacter species in Japan.
    Matsui M; Suzuki S; Yamane K; Suzuki M; Konda T; Arakawa Y; Shibayama K
    J Med Microbiol; 2014 Jun; 63(Pt 6):870-877. PubMed ID: 24600014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of carbapenem resistance in Acinetobacter pittii and Acinetobacter nosocomialis isolates from Thailand.
    Singkham-In U; Chatsuwan T
    J Med Microbiol; 2018 Dec; 67(12):1667-1672. PubMed ID: 30311872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct detection of carbapenemase-associated proteins of Acinetobacter baumannii using nanodiamonds coupled with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Chang KC; Chung CY; Yeh CH; Hsu KH; Chin YC; Huang SS; Liu BR; Chen HA; Hu A; Soo PC; Peng WP
    J Microbiol Methods; 2018 Apr; 147():36-42. PubMed ID: 29499232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early detection of metallo-β-lactamase NDM-1- and OXA-23 carbapenemase-producing Acinetobacter baumannii in Libyan hospitals.
    Mathlouthi N; El Salabi AA; Ben Jomàa-Jemili M; Bakour S; Al-Bayssari C; Zorgani AA; Kraiema A; Elahmer O; Okdah L; Rolain JM; Chouchani C
    Int J Antimicrob Agents; 2016 Jul; 48(1):46-50. PubMed ID: 27216382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loop-mediated isothermal amplification: Rapid and sensitive detection of the antibiotic resistance gene ISAba1-blaOXA-51-like in Acinetobacter baumannii.
    Mu X; Nakano R; Nakano A; Ubagai T; Kikuchi-Ueda T; Tansho-Nagakawa S; Kikuchi H; Kamoshida G; Endo S; Yano H; Ono Y
    J Microbiol Methods; 2016 Feb; 121():36-40. PubMed ID: 26707336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of carbapenem-resistant Acinetobacter calcoaceticus-baumannii complex isolates from nosocomial bloodstream infections in southern Iran.
    Pourabbas B; Firouzi R; Pouladfar G
    J Med Microbiol; 2016 Mar; 65(3):235-239. PubMed ID: 26747061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular epidemiology, antimicrobial susceptibility and carbapenemase resistance determinants among Acinetobacter baumannii clinical isolates in Taiwan.
    Chuang YC; Sheng WH; Lauderdale TL; Li SY; Wang JT; Chen YC; Chang SC
    J Microbiol Immunol Infect; 2014 Aug; 47(4):324-32. PubMed ID: 23726465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiology of carbapenem non-susceptible Acinetobacter nosocomialis in a medical center in Taiwan.
    Yang YS; Lee YT; Wang YC; Chiu CH; Kuo SC; Sun JR; Yin T; Chen TL; Lin JC; Fung CP; Chang FY
    Infect Genet Evol; 2015 Apr; 31():305-11. PubMed ID: 25724091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.